HIF1A and nasopharyngeal carcinoma: miR-144, enriched in tumor-derived extracellular vesicles (EVs) from nasopharyngeal carcinoma (NPC), is demonstrated in vitro and in vivo to promote angiogenesis by downregulating FBXW7 and promoting HIF-1α-induced VEGF-A expression (94).